You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Controlled Trial Of Budesonide Given By The Nebuhaler In Preschool Children With Asthma
J. G. A. Gleeson and J. F. Price
BMJ: British Medical Journal
Vol. 297, No. 6642 (Jul. 16, 1988), pp. 163-166
Published by: BMJ
Stable URL: http://www.jstor.org/stable/29700189
Page Count: 4
You can always find the topics here!Topics: Asthma, Children, Preschool children, Placebos, Peak expiratory flow rate, Corticosteroids, Bronchodilators, Dosage, Aerosols, Cough
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Objective—To determine whether the inhaled corticosteroid budesonide, given by a Nebuhaler spacing device, was effective in prophylaxis of asthma in preschool children. Design—Double blind, placebo controlled, random order crossover trial with two week practice run in period. Setting—Outpatient clinic referrals in secondary referral centre. Patients—39 children aged 2-6 years selected for the following: able to use Nebuhaler; parents able to complete record card; poorly controlled asthma (defined); not already on systemic or inhaled steroids. Eleven withdrew for various reasons not connected with intolerance to budesonide. Age, sex, other atopies, and symptoms during run in period were similar in the 28 children who completed the trial and in the 11 who withdrew. Interventions—Budesonide 200 μg or placebo (both one puff) given twice daily during 6-week treatment or control periods, using Nebuhaler after prior training. Three week "washout" at crossover. Compliance monitored by weighing canisters. Patients withdrawn if their acute attacks required treatment with systemic steroids. End point—Control of asthma. Measurements and main results—Peak expiratory flow rate measured twice daily where cooperation allowed. Diary of symptoms and concomitant drug use kept daily. Results showed mean peak flow significantly higher (12% in mornings, 14% in evenings) in second three weeks of intervention compared with control period (95% confidence intervals 6.3-17.3% and 7.2-21.0%). Supplementary bronchodilator drugs reduced by 50% during intervention periods. Conclusions—Budesonide given by Nebuhaler is effective prophylaxis for preschool children with frequent asthma.
BMJ: British Medical Journal © 1988 BMJ